drugset / Trial / NCT07598214
Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients
NaSingle-groupOpen-labelTreatment
Summary
The current study aims to investigate the protective properties of diosmin/hesperidin on cisplatin-induced nephrotoxicity.
Timeline
- Start
- 2025-02-03
- Primary completion
- 2026-11-03
- Completion
- 2026-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diosmin | Small molecule | 450 mg | Oral |
| Subject | Hesperidin | Small molecule | 50 mg | Oral |